ANTI-TUMOR NECROSIS FACTOR-α MONOCLONAL ANTIBODY THERAPY FOR RHEUMATOID ARTHRITIS
- 1 August 1998
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 24 (3), 593-614
- https://doi.org/10.1016/s0889-857x(05)70028-4
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Antiadhesion Therapy in Rheumatoid ArthritisBioDrugs, 1997
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cellsInternational Journal of Immunopharmacology, 1993
- Tumor necrosis factor α in autoimmunity: pretty girl or old witch?Immunology Today, 1992
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Tumour necrosis factor in synovial exudates.Annals Of The Rheumatic Diseases, 1988
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984